KLK7 and thyroid gland carcinoma: Zhang et al. (15) confirmed that NEAT1 is upregulated in thyroid carcinoma, and that its upregulation can inhibit the action of miRNA-129-5p and upregulate kallikrein-related peptidase 7 (KLK7) expression.